Modular Total Synthesis and Antimycobacterial Activity of Rufomycins
Organic Letters · 2024
DOI: 10.1021/acs.orglett.4c04163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, 2024. Verfasst von Max J Bedding und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Mycobacterium tuberculosis, Peptides, Cyclic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
- Tuberculosis Research Program, Centenary Institute, and Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia.
ORCID-Profile: Andrew M Giltrap, Richard J Payne
Förderung
- National Health and Medical Research Council
- Australian Research Council
Zitieren
APA
Bedding, M. J., Forster, B. C., Giltrap, A. M., Stevens, M. T., Corcilius, L., Britton, W. J., & Payne, R. J. (2024). Modular Total Synthesis and Antimycobacterial Activity of Rufomycins. Organic Letters. https://doi.org/10.1021/acs.orglett.4c04163
Vancouver
Bedding MJ, Forster BC, Giltrap AM, Stevens MT, Corcilius L, Britton WJ, et al. Modular Total Synthesis and Antimycobacterial Activity of Rufomycins. Organic Letters. 2024. doi:10.1021/acs.orglett.4c04163
BibTeX
@article{Bedding2024,
author = {Bedding, Max J and Forster, Bryton C and Giltrap, Andrew M and Stevens, Maxwell T and Corcilius, Leo and Britton, Warwick J and Payne, Richard J},
title = {Modular Total Synthesis and Antimycobacterial Activity of Rufomycins},
journal = {Organic Letters},
year = {2024},
doi = {10.1021/acs.orglett.4c04163}
}
EUVIMED